Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
400 participants
INTERVENTIONAL
2002-03-01
2026-03-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PET/MR Radiomics for Breast Cancer Diagnosis
NCT05466760
Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI
NCT02587663
Comparison of Positron Emission Mammography and Contrast-enhanced Breast MRI
NCT02770586
Development of Artificial Intelligence System for Detection and Diagnosis of Breast Lesion Using Mammography
NCT03708978
FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
NCT01864083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients Diagnosed with Breast Cancer
MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI, Digital Mammography, Ultrasound and Positron Emission Tomography (PET)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Will be undergoing surgery (after study) at the Hospital of the University of Pennsylvania
Exclusion Criteria
* previously diagnosed with breast cancer (in the smae breast) within the past 5 years
* Patients with known locally advanced cancer (prior to study entry) being treated with preoperative adjuvant therapy.
* Pregnant women
18 Years
80 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abass Alavi, MD
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIH funded
Identifier Type: -
Identifier Source: secondary_id
Protocol 414500
Identifier Type: -
Identifier Source: org_study_id
NCT00194337
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.